• Latest Posts

Hope for Alzheimer’s patients after Lilly drug results

Partnership to progress neurodegenerative disorder treatments

FDA approves Alzheimer’s treatment

SandboxAQ launches new division to boost drug development

Alchemab Therapeutics unveils Alzheimer’s candidate  

‘Clinical trial in a dish’ for Alzheimer’s disease

ADVERTISEMENT
In Depth 13 Jun 2023

Abeta-targeting antibodies pave the way for Alzheimer’s disease vaccines

How AI can advance research and treatment of CNS disorders

New study reveals Alzheimer’s inflammation protection

Researchers discover genetic variation offers Alzheimer’s disease clues

Cancer implications as new molecule can kill ‘zombie’ cells

Researchers’ mutation discovery offers new Alzheimer’s hope

ADVERTISEMENT